Evidence map›Paper›PMID 19923790›Full record

Trial reportRespiration; international review of thoracic diseases2010

A multicenter pilot study of a bronchial valve for the treatment of severe emphysema.

D H Sterman, A C Mehta, D E Wood, P N Mathur, R J McKenna, D E Ost, J D Truwit, P Diaz, M M Wahidi, R Cerfolio and 9 more

Registry-linked trialOpen access · bronzeAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in Respiration; international review of thoracic diseases, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03010449 (A Single Arm Pilot Study of Lung Volume Reduction in Severe Emphysema Using Bronchoscopic Autologous Blood Instillation in Combination With Intra-bronchial Valves), which is not on this map. Cited by 30 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 4 pooled it
10.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03010449 naunknown statusnot on this mapstarted 2017, after this paper: background citation

A Single Arm Pilot Study of Lung Volume Reduction in Severe Emphysema Using Bronchoscopic Autologous Blood Instillation in Combination With Intra-bronchial Valves

TypeinterventionalSponsorRoyal Brompton & Harefield NHS Foundation TrustRan2017 to 2020Enrolled20ConditionsChronic Obstructive Pulmonary Disease, EmphysemaArmsIntra-bronchial valve and blood
3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 4 syntheses or guidelines pooled it, 131 citations in OpenAlex.

  1. Pooled it
  2. Endobronchial valves in treatment of persistent air leaks: a systematic review of clinical evidence.Medical science monitor : international medical journal of experimental and clinical research · 2015
    Pooled it
  3. Efficacy of bronchoscopic lung volume reduction: a meta-analysis.International journal of chronic obstructive pulmonary disease · 2014
    Pooled it
  4. Guideline
  5. Trial
  6. Trial
  7. Review
  8. Review
  9. Article
  10. Endobronchial valves for severe emphysema.European respiratory review : an official journal of the European Respiratory Society · 2019
    Review
  11. Article
  12. Article
  13. Bronchoscopic treatment of emphysema: an update.Journal of thoracic disease · 2018
    Review
  14. Review
  15. Review
  16. Article
  17. Endobronchial valves for bronchopleural fistula: pitfalls and principles.Therapeutic advances in respiratory disease · 2017
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 11 institutions in 1 country.

D H StermanUniversity of Pennsylvania Medical Center, Philadelphia, PA 19104-4283, USA. daniel.sterman@uphs.upenn.edu
A C Mehta
D E Wood
P N Mathur
R J McKenna
D E Ost
J D Truwit
P Diaz
M M Wahidi
R Cerfolio
R Maxfield
A I Musani
T Gildea
F Sheski
M Machuzak
A R Haas
H X Gonzalez
S C Springmeyer
IBV Valve US Pilot Trial Research Team
University of Pennsylvania · USCleveland Clinic · USUniversity of Washington · USCedars-Sinai Medical Center · USColumbia University · USDuke University · USIndiana University Hospital · USNorthwell Health · USThe Ohio State University · USUniversity of Alabama at Birmingham · USUniversity of Virginia Health System · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Fabien Delerue · 1985 to 2026
$290.8M
ZACOPRIDE VS METOCLOPRAMIDE--EFFECT ON LOWER ESOPHAGEAL SPHINCTERM01RR000847 · NCRR · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI ALTES, TALISSA A · 1985 to 2010
$48.1M
Biology of Leukotrienes in the Pathogenesis of EmphysemaK08HL091127 · NHLBI · UNIVERSITY OF VIRGINIA · PI SHIM, YUN MICHAEL · 2008 to 2012
$643k
6 · The paper itself

Abstract

backgroundChronic obstructive pulmonary disease (COPD) affects millions of people and has limited treatment options. Surgical treatments for severe COPD with emphysema are effective for highly selected patients. A minimally invasive method for treating emphysema could decrease morbidity and increase acceptance by patients.

objectiveTo study the safety and effectiveness of the IBV(R) Valve for the treatment of severe emphysema.

methodsA multicenter study treated 91 patients with severe obstruction, hyperinflation and upper lobe (UL)-predominant emphysema with 609 bronchial valves placed bilaterally into ULs.

resultsValves were placed in desired airways with 99.7% technical success and no migration or erosion. There were no procedure-related deaths and 30-day morbidity and mortality were 5.5 and 1.1%, respectively. Pneumothorax was the most frequent serious device-related complication and primarily occurred when all segments of a lobe, especially the left UL, were occluded. Highly significant health-related quality of life (HRQL) improvement (-8.2 +/- 16.2, mean +/- SD change at 6 months) was observed. HRQL improvement was associated with a decreased volume (mean -294 +/- 427 ml, p = 0.007) in the treated lobes without visible atelectasis. FEV(1), exercise tests, and total lung volume were not changed but there was a proportional shift, a redirection of inspired volume to the untreated lobes. Combined with perfusion scan changes, this suggests that there is improved ventilation and perfusion matching in non-UL lung parenchyma.

conclusionBronchial valve treatment of emphysema has multiple mechanisms of action and acceptable safety, and significantly improves quality of life for the majority of patients.

Indexed as

Prostheses and ImplantsAdultAgedBlood Gas AnalysisBronchoscopyDevice RemovalExercise TestFemaleHumansLung Volume MeasurementsMaleMiddle AgedOxygenPilot ProjectsPneumoniaPneumothoraxOxygen

Identifiers

PMID19923790
PMCPMC7068788
OpenAlexW2058909135

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.